BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//OTRADI - ECPv6.18.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.otradi.org
X-WR-CALDESC:Events for OTRADI
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20190310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20191103T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20200308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20201101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20210314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20211107T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20200728T130000
DTEND;TZID=America/Los_Angeles:20200728T140000
DTSTAMP:20200716T160341Z
CREATED:20200716T155847Z
LAST-MODIFIED:20200716T160341Z
UID:10000456-1595941200-1595944800@www.otradi.org
SUMMARY:SciEducate Webinar: Business Plans are a Research Endeavor
DESCRIPTION:Start-ups often look at a “Business Plan” as a necessary evil or a writing exercise.  Indeed\, if you plan to approach a financial institution for a loan\, apply for a small business or SBIR/STTR grant\, pitch your idea to investors\, or enlist the support of a partner\, a business plan is required. However\, I believe that writing a business plan can and should be more than that. The title says it is a research endeavor. In this webinar\, I’d like to convince you of that. A business plan can be an action plan. When you use your business plan as a tool to help you outline action items\, next steps\, and future activities\, you are creating a living\, breathing document. That kind of plan not only outlines where you are and where you want to be but also gives you the directions you need to get there. Lastly\, if the plan is periodically reviewed and updated\, it becomes increasingly valuable over time. It provides valuable historical information to help a business make decisions on the future direction of the company. \nDr. Bilello is a Ph.D. in Molecular Biology and was the former Director of Technology Development at GlaxoSmithKline. In addition to an established track record of innovative basic and clinical research\, Dr. Bilello has experience in both project and organizational management. As an entrepreneur\, Dr. Bilello was a founder of Ridge Diagnostics and a co-founder and Managing Partner of Innovalyst LLC. At Innovalyst\, he worked with companies from small businesses to Fortune 500 companies as well as “Invest NI” Northern Ireland’s regional economic development agency.
URL:https://www.otradi.org/event/business-plans-are-a-research-endeavor/
LOCATION:OR\, United States
CATEGORIES:Partner Programs/Events
GEO:43.8041334;-120.5542012
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20200519T130000
DTEND;TZID=America/Los_Angeles:20200519T140000
DTSTAMP:20200519T194552Z
CREATED:20200519T194552Z
LAST-MODIFIED:20200519T194552Z
UID:10000175-1589893200-1589896800@www.otradi.org
SUMMARY:Lessons Learned: Statistical Analysis for IRB Protocols
DESCRIPTION:What do you do when you’re an experienced principal investigator\, but a novice statistician for IRB studies? Preparing a protocol for an IRB is not only challenging but has far-reaching consequences. Tune in to find out how performing statistical analysis for an IRB study is a vital component of any protocol. \nQ/A to follow. \nDr. Analee Miranda – Researcher\, Educator and Consultant. \nDr. Miranda has over a ten years’ experience working on developing technological solutions for the Department of Defense. In collaboration with the Air Force Research Lab\, Dr. Miranda developed a patented biometric technology that uses static UHF/VHF radar scattering measurements\, dosimetry estimates and anthropologic measurements to uniquely identify individuals. She also consults on grant writing\, IRB protocol development\, educational research and scientific editing projects.
URL:https://www.otradi.org/event/lessons-learned-statistical-analysis-for-irb-protocols/
LOCATION:OR\, United States
CATEGORIES:Partner Programs/Events
GEO:37.09024;-95.712891
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20200602T130000
DTEND;TZID=America/Los_Angeles:20200602T140000
DTSTAMP:20200519T194140Z
CREATED:20200519T194140Z
LAST-MODIFIED:20200519T194140Z
UID:10000425-1591102800-1591106400@www.otradi.org
SUMMARY:Overview of SBIR Funding – NIH vs NSF
DESCRIPTION:New to SBIR funding? As you launch your new business\, understanding the overall structure of the SBIR program and different funding opportunities is key to a successful application. The “ten best tips” for a competitive proposal will be discussed.  Join us for a webinar with ScienceDocs as Dr. Pam Lucchesi shares her long-term experience as a seasoned NIH SBIR grant reviewer and discusses the “Ten Best Tips” for competitive proposals. \nQ/A to follow. \nDr. Pam Lucchesi – Researcher\, Educator and Consultant. \nDr. Lucchesi received her PhD in Biomedical Sciences from UMASS Medical school and is an elected fellow of the American Heart Association and the American Physiological Society. She has a 30-year track record of continuous extramural funding related to cardiovascular disease and has mentored numerous fellows\, junior faculty\, and small business owners. 
URL:https://www.otradi.org/event/overview-of-sbir-funding-nih-vs-nsf/
LOCATION:OR\, United States
CATEGORIES:Partner Programs/Events
GEO:37.09024;-95.712891
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20200505T130000
DTEND;TZID=America/Los_Angeles:20200505T140000
DTSTAMP:20200501T165253Z
CREATED:20200424T203528Z
LAST-MODIFIED:20200501T165253Z
UID:10000416-1588683600-1588687200@www.otradi.org
SUMMARY:Creating an Effective Biotech Pitch Deck
DESCRIPTION:A pitch deck to investors is a “make it” or “break it” event for entrepreneurs and likely your only chance to convince investors of your technology’s value. Presenting your idea to biotechnology investors differs from other industries due to longer development timelines\, development costs\, navigating the FDA\, and years before turning a profit. Join us for our next ScienceDocs webinar\, as Dr. Schwartz discusses some of the most important “do’s” and “don’ts” of how to pitch your idea to investors. \nDr. Schwartz \nDr. Schwartz is a serial entrepreneur specializing in the launch of new companies from technologies originating from academic and government organizations.  He has been the co-founder and/or CEO of approximately ten companies\, mainly focused on the HealthIT/Biotechnology sectors. His efforts have raised millions in VC and grant funding. As a result\, these efforts led to FDA approval of a medical device and the progression of multiple oncology drug programs through IND to the clinic. At ScienceDocs\, he helps entrepreneurs and startup companies with developing business plans\, licensing\, funding raising\, and pre-clinical/clinical development pathways in the pharmaceutical and medical device space.
URL:https://www.otradi.org/event/creating-an-effective-biotech-pitch-deck/
LOCATION:OR\, United States
CATEGORIES:Partner Programs/Events
GEO:43.8041334;-120.5542012
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20200428T130000
DTEND;TZID=America/Los_Angeles:20200428T140000
DTSTAMP:20200424T211325Z
CREATED:20200424T203250Z
LAST-MODIFIED:20200424T211325Z
UID:10000415-1588078800-1588082400@www.otradi.org
SUMMARY:Choosing the Right CRO
DESCRIPTION:Collaborating with the right CRO partner is challenging! Now more than ever\, outsourcing has become increasingly essential. Not every CRO is alike and you wouldn’t trust your research project with just anyone. Join us for a webinar with ScienceDocs as Dr. Judith Gorski\, Pharmacology Expert\, walks through some tangible tips to choosing the right CRO partner. \nDr. Judith Gorski – Pharmacology Writer and Consultant \nDr. Gorski has more than 20 years of experience within the Life Sciences Industry\, managing successful biopharmaceutical preclinical programs and driving successful CRO relationships. She served as a Principal Investigator at Merck and Co.\, Inc. where she was responsible for developing and executing collaboratively a range of complicated research operating protocols from Target ID to IND filing for research of drug candidates across multiple therapeutic areas. As Senior Director of Business Development at Crown Biosciences\, Dr. Gorski engaged with research leaders around the world from both small and large pharmaceutical companies to design and execute significant studies to drive their drug discovery pipelines.
URL:https://www.otradi.org/event/choosing-the-right-cro/
LOCATION:OR\, United States
CATEGORIES:Partner Programs/Events
GEO:43.8041334;-120.5542012
END:VEVENT
END:VCALENDAR